Cash flow Eli Lilly and Company

Equities

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-02-10 pm EST			Pre-market 08:19:24 am
1,025.00 ^USD	-1.88%		1,029.50	+0.44%

06:03am	CICC Adjusts Price Target on Eli Lilly and Co. to $1,107 From $1,060, Maintains Neutral Rating	MT
12:27am	Lilly's bowel disease drug gets approval in China	RE

1540c74d94b3.C5kRK14HtSb-UFd2usSvPAFPuq6R3HBGcv_w0PTVyec.e_5nEhJQhV6_Mxkj64KWDUx30pj3iyV1O7iHhoG8ub8y-yFHbX7yab8zIA

Published financial data: ELI LILLY AND COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	24.54B	28.32B	28.54B	34.12B	45.04B
Total Revenues	24.54B	28.32B	28.54B	34.12B	45.04B
Cost of Goods Sold, Total	5.48B	6.97B	6.63B	7.08B	8.42B
Gross Profit	19.06B	21.35B	21.91B	27.04B	36.62B
Selling General & Admin Expenses, Total	5.87B	6.14B	6.07B	6.94B	8.13B
R&D Expenses	6.09B	7.03B	7.19B	9.31B	10.99B
Other Operating Expenses, Total	11.96B	13.17B	13.26B	16.25B	19.12B
Operating Income	7.1B	8.18B	8.65B	10.79B	17.5B
Interest Expense, Total	-360M	-340M	-332M	-486M	-781M
Interest And Investment Income	33M	25.4M	62.8M	174M	175M
Net Interest Expenses	-327M	-314M	-269M	-312M	-605M
Currency Exchange Gains (Loss)	124M	-205M	-191M	-26.4M	-288M
Other Non Operating Income (Expenses)	-316M	-85.1M	177M	-6.3M	263M
EBT, Excl. Unusual Items	6.58B	7.57B	8.37B	10.44B	16.87B
Restructuring Charges	-151M	-13M	-23M	-45.5M	-
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	1.44B	518M	-411M	-20.2M	-49.5M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-	-
In Process R&D Expenses	-660M	-875M	-908M	-3.8B	-3.28B
Legal Settlements	-	-	-	-	-435M
Other Unusual Items	20M	-1.05B	-222M	-22.2M	-426M
EBT, Incl. Unusual Items	7.23B	6.16B	6.81B	6.55B	12.68B
Income Tax Expense	1.04B	574M	562M	1.31B	2.09B
Earnings From Continuing Operations	6.19B	5.58B	6.24B	5.24B	10.59B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	6.19B	5.58B	6.24B	5.24B	10.59B
Net Income - (IS)	6.19B	5.58B	6.24B	5.24B	10.59B
Net Income to Common Incl Extra Items	6.19B	5.58B	6.24B	5.24B	10.59B
Net Income to Common Excl. Extra Items	6.19B	5.58B	6.24B	5.24B	10.59B
Per Share Items
Net EPS - Basic	6.82	6.15	6.93	5.82	11.76
Basic EPS - Continuing Operations	6.82	6.15	6.93	5.82	11.76
Basic Weighted Average Shares Outstanding	908M	907M	902M	900M	901M
Net EPS - Diluted	6.79	6.12	6.9	5.8	11.71
Diluted EPS - Continuing Operations	6.79	6.12	6.9	5.8	11.71
Diluted Weighted Average Shares Outstanding	913M	912M	905M	903M	904M
Normalized Basic EPS	4.53	5.22	5.8	7.25	11.71
Normalized Diluted EPS	4.51	5.19	5.78	7.23	11.66
Dividend Per Share	2.96	3.4	3.92	4.52	5.2
Payout Ratio	43.38	55.3	56.62	77.65	44.2
American Depositary Receipts Ratio (ADR)	0.03	0.03	0.03	0.03	0.03
Supplemental Items
EBITDA	8.43B	9.73B	10.18B	12.31B	19.27B
EBITA	7.53B	8.81B	9.23B	11.29B	18.05B
EBIT	7.1B	8.18B	8.65B	10.79B	17.5B
EBITDAR	8.58B	9.88B	10.32B	12.49B	19.48B
Effective Tax Rate - (Ratio)	14.33	9.32	8.25	20.05	16.49
Current Domestic Taxes	520M	910M	2.2B	3.04B	3.34B
Current Foreign Taxes	650M	466M	548M	613M	1.43B
Total Current Taxes	1.17B	1.38B	2.75B	3.66B	4.77B
Deferred Domestic Taxes	-118M	-977M	-2.11B	-2.38B	-2.21B
Deferred Foreign Taxes	-16.6M	175M	-78.2M	34.2M	-473M
Total Deferred Taxes	-134M	-802M	-2.19B	-2.34B	-2.68B
Normalized Net Income	4.11B	4.73B	5.23B	6.53B	10.54B
Interest Capitalized	-	-	-	-	-
Non-Cash Pension Expense	-74.9M	-120M	-205M	-282M	-323M
Supplemental Operating Expense Items
Advertising Expense	1.1B	1.2B	1B	1.12B	1.44B
Selling and Marketing Expenses	1.1B	1.2B	1B	1.12B	1.44B
Research And Development Expense From Footnotes	6.75B	7.9B	8.1B	13.11B	14.27B
Net Rental Expense, Total	155M	159M	149M	171M	210M
Imputed Operating Lease Interest Expense	27.02M	25.12M	23.17M	31.07M	42.65M
Imputed Operating Lease Depreciation	128M	134M	126M	140M	167M
Stock-Based Comp., Other (Total)	308M	343M	371M	628M	646M
Total Stock-Based Compensation	308M	343M	371M	628M	646M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	3.66B	3.82B	2.07B	2.82B	3.27B
Short Term Investments	24.2M	90.1M	145M	109M	155M
Trading Asset Securities, Total	-	4.8M	230M	114M	10.3M
Total Cash And Short Term Investments	3.68B	3.91B	2.44B	3.04B	3.43B
Accounts Receivable, Total	5.88B	6.67B	6.9B	9.09B	11.01B
Other Receivables	1.01B	1.44B	1.41B	2B	1.92B
Total Receivables	6.89B	8.11B	8.3B	11.09B	12.93B
Inventory	3.98B	3.89B	4.31B	5.77B	7.59B
Prepaid Expenses	2.87B	2.53B	2.95B	5.54B	8.34B
Other Current Assets, Total	41.1M	9.9M	26.6M	279M	448M
Total Current Assets	17.46B	18.45B	18.03B	25.73B	32.74B
Gross Property Plant And Equipment	18.25B	18.96B	20.38B	24.01B	29.94B
Accumulated Depreciation	-9.57B	-9.98B	-10.23B	-11.1B	-11.79B
Net Property Plant And Equipment	8.68B	8.99B	10.14B	12.91B	18.15B
Long-term Investments	3.2B	3.4B	3.2B	3.41B	3.27B
Goodwill	3.77B	3.89B	4.07B	4.94B	5.77B
Other Intangibles, Total	7.45B	7.69B	7.21B	6.91B	6.17B
Deferred Tax Assets Long-Term	2.83B	2.49B	2.79B	5.48B	8B
Other Long-Term Assets, Total	3.24B	3.89B	4.04B	4.64B	4.62B
Total Assets	46.63B	48.81B	49.49B	64.01B	78.71B
Liabilities
Accounts Payable, Total	1.61B	1.67B	1.93B	2.6B	3.23B
Accrued Expenses, Total	6.93B	7.88B	9.92B	13.42B	13.71B
Short-term Borrowings	-	-	-	6.19B	4.34B
Current Portion of Long-Term Debt	101M	1.54B	1.54B	746M	782M
Current Portion of Leases	151M	148M	154M	197M	176M
Current Income Taxes Payable	495M	127M	475M	-	-
Other Current Liabilities	3.2B	3.69B	3.12B	4.14B	6.14B
Total Current Liabilities	12.48B	15.05B	17.14B	27.29B	28.38B
Long-Term Debt	16.78B	15.39B	14.87B	18.42B	28.64B
Long-Term Leases	513M	537M	574M	910M	971M
Pension & Other Post Retirement Benefits	4.09B	1.95B	1.31B	1.44B	1.3B
Deferred Tax Liability Non Current	2.1B	1.73B	87.3M	-	-
Other Non Current Liabilities	4.83B	4.99B	4.74B	5.08B	5.15B
Total Liabilities	40.81B	39.65B	38.71B	53.14B	64.44B
Common Stock, Total	598M	596M	594M	594M	592M
Additional Paid In Capital	6.78B	6.83B	6.92B	7.25B	7.44B
Retained Earnings	7.83B	8.96B	10.04B	10.31B	13.54B
Treasury Stock	-55.7M	-52.7M	-50.5M	-44.2M	-49.5M
Comprehensive Income and Other	-9.51B	-7.36B	-6.86B	-7.34B	-7.34B
Total Common Equity	5.64B	8.98B	10.65B	10.77B	14.19B
Minority Interest	184M	176M	126M	91.8M	79.5M
Total Equity	5.83B	9.15B	10.78B	10.86B	14.27B
Total Liabilities And Equity	46.63B	48.81B	49.49B	64.01B	78.71B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	908M	902M	900M	900M	898M
ECS Total Common Shares Outstanding	907M	904M	900M	899M	898M
Book Value / Share	6.22	9.94	11.83	11.98	15.81
Tangible Book Value	-5.57B	-2.6B	-630M	-1.07B	2.26B
Tangible Book Value Per Share	-6.15	-2.88	-0.7	-1.19	2.51
Total Debt	17.55B	17.61B	17.14B	26.47B	34.91B
Net Debt	13.87B	12.42B	14.01B	22.71B	30.99B
Debt Equivalent of Unfunded Proj. Benefit Obligation	3.65B	1.15B	26.2M	549M	-243M
Debt Equivalent Oper. Leases	1.24B	1.28B	1.19B	1.37B	1.68B
Minority Interest, Total (Incl. Fin. Div)	184M	176M	126M	91.8M	79.5M
Equity Method Investments, Total	472M	772M	781M	962M	1.14B
Account Code - Inventory Valuation	4	4	4	4	4
LIFO Reserve, Total	34.8M	34.2M	8.9M	102M	62.9M
Inventories - Raw Materials, Total	651M	717M	802M	1.63B	2.33B
Inventories - Work In Process, Total	2.54B	2.37B	2.6B	3.25B	3.98B
Inventories - Finished Goods, Total	759M	762M	901M	792M	1.22B
Land - (BS)	227M	259M	257M	320M	382M
Buildings, Total	7.33B	7.59B	7.92B	8.28B	8.81B
Machinery, Total	8.56B	8.94B	9.41B	10.33B	11.46B
Full Time Employees	35K	35K	39K	43K	47K
Accumulated Allowance for Doubtful Accounts (Supple)	25.9M	22.5M	16M	14.8M	14.9M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	6.19B	5.58B	6.24B	5.24B	10.59B
Depreciation & Amortization - CF	896M	919M	943M	1.02B	1.21B
Amortization of Goodwill and Intangible Assets - (CF)	428M	629M	580M	506M	553M
Depreciation & Amortization, Total	1.32B	1.55B	1.52B	1.53B	1.77B
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-1.88B	-224M
(Gain) Loss on Sale of Investments - (CF)	-1.44B	-178M	420M	23.5M	49.8M
Asset Writedown & Restructuring Costs	660M	875M	421M	3.8B	3.28B
Stock-Based Compensation (CF)	308M	343M	371M	628M	646M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	199M	114M	-1.88B	-2.05B	-1.91B
Change In Accounts Receivable	-1.35B	-1.28B	-300M	-2.45B	-2.16B
Change In Inventories	-533M	-236M	-600M	-1.42B	-2.51B
Change In Accounts Payable	1.27B	-664M	1.33B	4.27B	2.61B
Change In Income Taxes	322M	-360M	347M	-	-
Change in Other Net Operating Assets	-457M	1.52B	-794M	-3.45B	-3.33B
Cash from Operations	6.5B	7.26B	7.08B	4.24B	8.82B
Capital Expenditure	-1.39B	-1.31B	-1.85B	-3.45B	-5.06B
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-849M	-747M	-327M	-1.04B	-948M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-641M	-563M	-630M	-2.34B	-2.74B
Investment in Marketable and Equity Securities, Total	517M	-166M	-244M	-129M	-253M
Other Investing Activities, Total	103M	24.3M	-206M	-192M	-298M
Cash from Investing	-2.26B	-2.76B	-3.26B	-7.15B	-9.3B
Short Term Debt Issued, Total	-	-	1.5B	4.69B	-
Long-Term Debt Issued, Total	2.06B	2.41B	-	3.96B	11.42B
Total Debt Issued	2.06B	2.41B	1.5B	8.65B	11.42B
Short Term Debt Repaid, Total	-1.49B	-4M	-	-	-1.85B
Long-Term Debt Repaid, Total	-276M	-1.91B	-1.56B	-	-664M
Total Debt Repaid	-1.77B	-1.91B	-1.56B	-	-2.52B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-500M	-1.25B	-1.5B	-750M	-2.5B
Common Dividends Paid	-2.69B	-3.09B	-3.54B	-4.07B	-4.68B
Common & Preferred Stock Dividends Paid	-2.69B	-3.09B	-3.54B	-4.07B	-4.68B
Other Financing Activities, Total	-242M	-296M	-309M	-335M	-491M
Cash from Financing	-3.14B	-4.13B	-5.41B	3.5B	1.23B
Foreign Exchange Rate Adjustments	216M	-206M	-168M	169M	-297M
Net Change in Cash	1.32B	161M	-1.75B	752M	450M
Supplemental Items
Cash Interest Paid	346M	338M	324M	404M	578M
Cash Income Tax Paid (Refund)	955M	1.6B	2.67B	5.56B	6.56B
Levered Free Cash Flow	3.28B	5.14B	5.49B	237M	1.32B
Unlevered Free Cash Flow	3.51B	5.35B	5.7B	541M	1.81B
Change In Net Working Capital	535M	-226M	-878M	2.57B	3.74B
Net Debt Issued / Repaid	292M	501M	-62M	8.65B	8.9B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	10.33	10.71	11	11.88	15.33
Return on Total Capital	21.42	20.66	20.03	20.91	25.29
Return On Equity %	145.32	74.52	62.67	48.43	84.26
Return on Common Equity	150.18	76.35	63.63	48.93	84.84
Margin Analysis
Gross Profit Margin %	77.66	75.38	76.77	79.25	81.31
SG&A Margin	23.92	21.69	21.26	20.34	18.05
EBITDA Margin %	34.33	34.34	35.65	36.09	42.78
EBITA Margin %	30.68	31.1	32.35	33.09	40.08
EBIT Margin %	28.94	28.88	30.32	31.61	38.86
Income From Continuing Operations Margin %	25.24	19.71	21.88	15.36	23.51
Net Income Margin %	25.24	19.71	21.88	15.36	23.51
Net Avail. For Common Margin %	25.24	19.71	21.88	15.36	23.51
Normalized Net Income Margin	16.77	16.71	18.33	19.13	23.41
Levered Free Cash Flow Margin	13.37	18.16	19.23	0.69	2.93
Unlevered Free Cash Flow Margin	14.29	18.91	19.96	1.58	4.01
Asset Turnover
Asset Turnover	0.57	0.59	0.58	0.6	0.63
Fixed Assets Turnover	2.96	3.21	2.98	2.96	2.81
Receivables Turnover (Average Receivables)	4.71	4.51	4.21	4.27	4.48
Inventory Turnover (Average Inventory)	1.53	1.77	1.62	1.4	1.26
Short Term Liquidity
Current Ratio	1.4	1.23	1.05	0.94	1.15
Quick Ratio	0.85	0.8	0.63	0.52	0.58
Operating Cash Flow to Current Liabilities	0.52	0.48	0.41	0.16	0.31
Days Sales Outstanding (Average Receivables)	77.72	80.87	86.76	85.5	81.65
Days Outstanding Inventory (Average Inventory)	239.33	205.88	225.6	259.81	290.47
Average Days Payable Outstanding	87.87	86.95	93.18	96.73	104.2
Cash Conversion Cycle (Average Days)	229.18	199.79	219.19	248.58	267.92
Long Term Solvency
Total Debt/Equity	301.27	192.38	159.06	243.63	244.62
Total Debt / Total Capital	75.08	65.8	61.4	70.9	70.98
LT Debt/Equity	296.94	173.94	143.34	177.98	207.52
Long-Term Debt / Total Capital	74	59.49	55.33	51.79	60.22
Total Liabilities / Total Assets	87.51	81.24	78.23	83.03	81.87
EBIT / Interest Expense	19.75	24.07	26.1	22.2	22.42
EBITDA / Interest Expense	23.86	29.09	31.14	25.7	24.95
(EBITDA - Capex) / Interest Expense	20	25.23	25.54	18.6	18.47
Total Debt / EBITDA	2.05	1.78	1.66	2.12	1.79
Net Debt / EBITDA	1.62	1.26	1.36	1.82	1.59
Total Debt / (EBITDA - Capex)	2.44	2.05	2.02	2.93	2.42
Net Debt / (EBITDA - Capex)	1.93	1.45	1.65	2.51	2.15
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.95	15.4	0.79	19.56	32
Gross Profit, 1 Yr. Growth %	8.29	12.01	2.65	23.41	35.44
EBITDA, 1 Yr. Growth %	16.5	15.43	3.62	21.02	56.47
EBITA, 1 Yr. Growth %	20.95	16.96	3.72	22.31	59.88
EBIT, 1 Yr. Growth %	18.37	15.15	4.6	24.66	62.24
Earnings From Cont. Operations, 1 Yr. Growth %	33.55	-9.88	11.88	-16.08	102.08
Net Income, 1 Yr. Growth %	-25.54	-9.88	11.88	-16.08	102.08
Normalized Net Income, 1 Yr. Growth %	17.08	15.11	4.5	24.76	61.56
Diluted EPS Before Extra, 1 Yr. Growth %	36.9	-9.87	12.74	-15.94	101.9
Accounts Receivable, 1 Yr. Growth %	29.2	13.57	3.34	31.82	21.07
Inventory, 1 Yr. Growth %	24.75	-2.37	10.9	33.95	31.46
Net Property, Plant and Equip., 1 Yr. Growth %	10.28	3.49	12.9	27.3	30.24
Total Assets, 1 Yr. Growth %	18.7	4.66	1.4	29.33	22.98
Tangible Book Value, 1 Yr. Growth %	-27.51	-53.28	-75.82	70.59	-309.93
Common Equity, 1 Yr. Growth %	116.41	59.16	18.61	1.15	31.75
Cash From Operations, 1 Yr. Growth %	34.38	11.71	-2.43	-44.1	107.96
Capital Expenditures, 1 Yr. Growth %	34.24	-5.63	41.57	85.92	46.7
Levered Free Cash Flow, 1 Yr. Growth %	-34.25	49.8	2.6	-95.51	375.58
Unlevered Free Cash Flow, 1 Yr. Growth %	-33.1	46.4	2.4	-90.14	211.04
Dividend Per Share, 1 Yr. Growth %	14.73	14.86	15.29	15.31	15.04
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.85	12.64	7.85	9.77	25.62
Gross Profit, 2 Yr. CAGR %	6.47	10.13	7.23	12.56	29.28
EBITDA, 2 Yr. CAGR %	5.05	15.96	9.19	11.98	37.61
EBITA, 2 Yr. CAGR %	8.58	18.94	9.94	12.63	39.84
EBIT, 2 Yr. CAGR %	8.56	16.75	9.55	14.19	42.22
Earnings From Cont. Operations, 2 Yr. CAGR %	40.21	9.7	0.41	-3.11	30.22
Net Income, 2 Yr. CAGR %	38.43	-18.08	0.41	-3.11	30.22
Normalized Net Income, 2 Yr. CAGR %	5.35	16.06	11.87	14.18	41.97
Diluted EPS Before Extra, 2 Yr. CAGR %	49.21	11.08	0.81	-2.65	30.27
Accounts Receivable, 2 Yr. CAGR %	13.09	21.14	8.34	16.72	26.33
Inventory, 2 Yr. CAGR %	13.35	10.36	4.06	21.88	32.7
Net Property, Plant and Equip., 2 Yr. CAGR %	4.2	6.83	8.09	19.88	33.77
Total Assets, 2 Yr. CAGR %	3.06	11.46	3.02	14.52	26.12
Tangible Book Value, 2 Yr. CAGR %	-13.17	-41.8	-66.39	-35.78	89.24
Common Equity, 2 Yr. CAGR %	-24.24	85.59	37.39	9.53	15.44
Cash From Operations, 2 Yr. CAGR %	8.47	22.52	4.4	-24.13	7.82
Capital Expenditures, 2 Yr. CAGR %	7.07	12.55	15.59	62.24	65.15
Levered Free Cash Flow, 2 Yr. CAGR %	146.69	1.5	25.21	-79.17	-49.98
Unlevered Free Cash Flow, 2 Yr. CAGR %	125.29	1.07	23.65	-69.13	-42.58
Dividend Per Share, 2 Yr. CAGR %	14.7	14.8	15.08	15.3	15.18
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.1	9.63	8.54	11.62	16.73
Gross Profit, 3 Yr. CAGR %	7.07	8.28	7.58	12.37	19.72
EBITDA, 3 Yr. CAGR %	10.39	8.4	12.06	13	25.19
EBITA, 3 Yr. CAGR %	13.43	11.3	14.04	13.92	26.58
EBIT, 3 Yr. CAGR %	14.78	10.71	12.99	14.37	28.37
Earnings From Cont. Operations, 3 Yr. CAGR %	315.41	21	10.42	-5.42	23.8
Net Income, 3 Yr. CAGR %	211.91	19.98	-9.11	-5.42	23.8
Normalized Net Income, 3 Yr. CAGR %	12.86	8.49	14.18	16.01	28.19
Diluted EPS Before Extra, 3 Yr. CAGR %	335.64	26.13	11.63	-5.12	24.15
Accounts Receivable, 3 Yr. CAGR %	8.92	13.25	14.89	15.66	18.15
Inventory, 3 Yr. CAGR %	-3.71	7.85	10.54	13.19	25
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.55	3.96	8.82	14.15	26.42
Total Assets, 3 Yr. CAGR %	1.21	3.59	8	11.13	17.27
Tangible Book Value, 3 Yr. CAGR %	20.42	-29.38	-56.57	-42.24	-4.68
Common Equity, 3 Yr. CAGR %	-21.34	-2.97	59.86	24.06	16.48
Cash From Operations, 3 Yr. CAGR %	4.99	9.54	13.57	-13.27	6.18
Capital Expenditures, 3 Yr. CAGR %	8.83	2.66	21.5	35.43	56.89
Levered Free Cash Flow, 3 Yr. CAGR %	15.69	112.05	3.22	-59.25	-37.71
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.77	97.9	2.81	-47.45	-31.69
Dividend Per Share, 3 Yr. CAGR %	12.48	14.75	14.96	15.15	15.21
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.22	5.94	7.4	9.69	15.08
Gross Profit, 5 Yr. CAGR %	5.01	6.59	7.13	9.97	15.79
EBITDA, 5 Yr. CAGR %	10.91	13.03	10.19	10.03	21.65
EBITA, 5 Yr. CAGR %	12.26	14.1	12.35	12.07	23.73
EBIT, 5 Yr. CAGR %	14.6	16.13	13	12.35	23.88
Earnings From Cont. Operations, 5 Yr. CAGR %	20.79	15.31	135.4	10.71	17.95
Net Income, 5 Yr. CAGR %	20.79	15.31	98.21	10.15	4.95
Normalized Net Income, 5 Yr. CAGR %	12.69	13.61	12.82	11.98	24.58
Diluted EPS Before Extra, 5 Yr. CAGR %	24.61	18.86	142.59	13.72	18.74
Accounts Receivable, 5 Yr. CAGR %	10.83	10.61	8.69	14.63	19.34
Inventory, 5 Yr. CAGR %	2.93	1.76	-0.68	13.26	18.92
Net Property, Plant and Equip., 5 Yr. CAGR %	1.51	1.72	2.82	10.06	18.18
Total Assets, 5 Yr. CAGR %	5.57	4.69	1.93	7.83	14.91
Tangible Book Value, 5 Yr. CAGR %	0.28	-14.43	-27.72	-32.01	-21.75
Common Equity, 5 Yr. CAGR %	-17.29	-8.51	-1.68	1.85	40.34
Cash From Operations, 5 Yr. CAGR %	17	8.4	4.76	-5.15	12.76
Capital Expenditures, 5 Yr. CAGR %	5.42	4.78	11.48	23.28	37.37
Levered Free Cash Flow, 5 Yr. CAGR %	2.69	12.52	20.96	-15.17	-23.36
Unlevered Free Cash Flow, 5 Yr. CAGR %	3.34	12.54	20.31	-4.79	-19.18
Dividend Per Share, 5 Yr. CAGR %	8.16	10.76	13.51	14.97	15.05